Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 2

2(28.6%)

Phase 1

1(14.3%)

7Total

N/A(4)

Phase 2(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05449067Not ApplicableCompleted

Nocturnal APD vs. CAPD in Non-diabetic ESKD

Role: collaborator

NCT04555226Not ApplicableRecruiting

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

Role: collaborator

NCT06244368Phase 2Recruiting

GVM±R in Patients With Relapsed or Refractory Aggressive NHL.

Role: collaborator

NCT06209931Unknown

RIRS With Tip Flexible Pressure-controlling Ureteral Access Sheath Versus Mini PCNLfor Kidney Stones

Role: lead

NCT06181019Phase 1Unknown

Acupuncture Combined With Mirabegron in the Treatment of OAB

Role: lead

NCT05201599Not ApplicableUnknown

Treatment of Upper Urinary Tract Stones With a Diameter≤2cm by Intelligent Pressure-controlled Flexible Ureteroscope

Role: collaborator

NCT02636231Phase 2Unknown

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Role: collaborator

NCT02734914Not ApplicableUnknown

Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure

Role: lead

All 8 trials loaded